Dana Horáková

Defining secondary progressive multiple sclerosis

Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis et al. · Brain · 2016 · 401 citations · Full text

Neurological Disorder, Disability, Clinical Neurology +22

Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study

Anna He, B. Merkel, J William L Brown et al. · The Lancet Neurology · 2020 · 401 citations · Full text

Disease Progression, Neurological Disorder, Clinical Epidemiology +7

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study

Jens Kühle, Giulio Disanto, Ruth Dobson et al. · Multiple Sclerosis Journal · 2015 · 290 citations

Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score

Philip L. De Jager, Lori B. Chibnik, Jing Cui et al. · The Lancet Neurology · 2009 · 264 citations · Full text

Disease Susceptibility, Clinical Algorithm, Medicine +14

Defining reliable disability outcomes in multiple sclerosis

Tomáš Kalinčík, Gary Cutter, Tim Spelman et al. · Brain · 2015 · 223 citations · Full text